Literature DB >> 28941194

Organ involvement pattern suggests subgroups within relapsing polychondritis: comment on the article by Dion et al.

Jun Shimizu1, Yoshihisa Yamano1, Kazuo Yudoh1, Noboru Suzuki1.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28941194     DOI： 10.1002/art.40330

Source DB:  PubMed          Journal:  Arthritis Rheumatol        ISSN： 2326-5191            Impact factor:   10.995


× No keyword cloud information.
  5 in total

1.  Risk factors for the recurrence of relapsing polychondritis.

Authors:  Tsuneyasu Yoshida; Hajime Yoshifuji; Mirei Shirakashi; Akiyoshi Nakakura; Kosaku Murakami; Koji Kitagori; Shuji Akizuki; Ran Nakashima; Koichiro Ohmura; Akio Morinobu
Journal:  Arthritis Res Ther       Date:  2022-05-30       Impact factor: 5.606

2.  Elucidation of predictors of disease progression in patients with relapsing polychondritis at the onset: potential impact on patient monitoring.

Authors:  Jun Shimizu; Yoshihisa Yamano; Kimito Kawahata; Noboru Suzuki
Journal:  BMC Rheumatol       Date:  2020-09-11

3.  Comparison of relapsing polychondritis patients with and without central nervous system involvement: A retrospective study of 181 patients.

Authors:  Xiaoyu Cao; Lixiu Zhu; Huijuan Li; Li Jiang; Dong Xu; Jiuliang Zhao; Jiaxin Zhou; Fengchun Zhang; Yong Hou; Xiaofeng Zeng
Journal:  Int J Immunopathol Pharmacol       Date:  2021 Jan-Dec       Impact factor: 3.219

4.  Relapsing polychondritis patients were divided into three subgroups: patients with respiratory involvement (R subgroup), patients with auricular involvement (A subgroup), and overlapping patients with both involvements (O subgroup), and each group had distinctive clinical characteristics.

Authors:  Jun Shimizu; Yoshihisa Yamano; Kimito Kawahata; Noboru Suzuki
Journal:  Medicine (Baltimore)       Date:  2018-10       Impact factor: 1.817

5.  Clinical phenotypes and prognostic factors of adult-onset Still's disease: data from a large inpatient cohort.

Authors:  Rui Li; Xiaolei Liu; Guangliang Chen; Guo Tang; Xiaoxiang Chen; Xuesong Liu; Juan Wang; Liangjing Lu
Journal:  Arthritis Res Ther       Date:  2021-12-08       Impact factor: 5.156
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.